Clinical Trial: TB Type and Spirometry Result vs. Functional Capacity Based on 6MWT in People With Post-TB Lung Disease

U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT07451899) titled 'TB Type and Spirometry Result vs. Functional Capacity Based on 6MWT in People With Post-TB Lung Disease' on Feb. 13.

Brief Summary: Post-Tuberculosis Lung Disease (PTLD) is defined as chronic respiratory impairment due to previous pulmonary TB. Children recovering from pulmonary TB undergo ongoing respiratory health challenges, including more frequent respiratory symptoms, reduced lung volumes, and a threefold higher rate of pulmonary dysfunction compared to healthy children. These conditions could lead to long-term health consequences such as difficulties in performing daily activities. Pulmonary function impairment in PTLD include...